Pharmacy

Your Article Summary

See Latest Articles

Medtronic Announces Two Worldwide Clinical Trials to Study Medical Device Interventions for Stroke
Medtronic, 06/25/09

Each year, approximately 795,000 people experience a new or recurrent stroke1 in the United States, and approximately a half million people in Western Europe are similarly afflicted. Medtronic Inc. announces two significant clinical trials related to medical device interventions for stroke. First enrollments in the global CRYSTAL AF trial have taken place. The trial will use the Reveal XT Insertable Cardiac Monitor to assess the incidence of atrial fibrillation in patients with cryptogenic stroke or transient ischemic attack in order to aid physicians in determining the optimal course of treatment for these patients.

Today in Drug Trials...keeping you current

Receive free subspecialty "5-minute updates" via email

Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: A randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers
Clinical Therapeutics, 12/01/09

Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trials
The Lancet - Early Online Publication, 12/01/09

Bayer Starts Phase III Trial with Florbetaben
BayNews International, 12/01/09

 See all of Drug Trials

Today in Neuro/Psych pharmacology...keeping you current

Receive free subspecialty "5-minute updates" via email

Systematic review of apomorphine infusion, levodopa infusion and deep brain stimulation in advanced Parkinson's disease
Parkinsonism & Related Disorders, 12/02/09

Effectiveness and tolerability of zonisamide in children with epilepsy: A retrospective review
Seizure - European Journal of Epilepsy, 12/02/09

A randomized controlled trial of rivastigmine in patients with cognitive impairment no dementia because of cerebrovascular disease
Acta Neurologica Scandinavica, 12/02/09

 See all of Neuro/Psych pharmacology